ETON
Eton Pharmaceuticals, Inc.
Key Financials
Net Income
$-4601000
↓ 20.4%
Revenue
$80.0M
↑ 104.9%
Gross Profit
$42.7M
↑ 82.6%
Operating Income
$-844000
↑ 67.5%
EPS (Diluted)
$0.41
N/A
Total Assets
$92.1M
↑ 21.0%
Cash & Equivalents
$25.9M
↑ 73.7%
Total Liabilities
$66.0M
↑ 27.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/13/2026 | View on SEC |
| 8-K | 8/13/2026 | View on SEC |
| 3 | 8/12/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
| 4 | 8/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ETON |
| Company Name | Eton Pharmaceuticals, Inc. |
| CIK | 1710340 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (847) 787-7361 |